Clinical Trial

Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy

Study acronym: CMR-ICD
Recruiting
View on ClinicalTrials.gov →
Summary
Patients with diagnostic CMR images for assessment of LGE/fibrosis and evidence/presence of non-ischaemic myocardial fibrosis/scar will be randomized to the following treatment groups in a 1:1 ratio: ICD group or Optimal HF care group.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-09-16; most recent amendment 2024-05-10.
Status change: Not Yet Recruiting → Recruiting 2021-01-19
Trial Details
NCT Number NCT04558723
Lead Sponsor Prof. Dr. med. Ingo Eitel
Collaborators: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Conditions Non-ischemic Dilated Cardiomyopathy
Enrollment 760 participants
Start Date 2021-01-14
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2024-05-13